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Abstract
Leprosy is an infectious disease caused by the obligate intracellular pathogen Mycobacterium leprae and remains endemic in
many parts of the world. Despite several major studies on susceptibility to leprosy, few genomic loci have been replicated
independently. We have conducted an association analysis of more than 1,500 individuals from different case-control and
family studies, and observed consistent associations between genetic variants in both TLR1 and the HLA-DRB1/DQA1 regions
with susceptibility to leprosy (TLR1 I602S, case-control P=5.7610
28, OR=0.31, 95% CI=0.20–0.48, and HLA-DQA1
rs1071630, case-control P=4.9610
214, OR=0.43, 95% CI=0.35–0.54). The effect sizes of these associations suggest that
TLR1 and HLA-DRB1/DQA1 are major susceptibility genes in susceptibility to leprosy. Further population differentiation
analysis shows that the TLR1 locus is extremely differentiated. The protective dysfunctional 602S allele is rare in Africa but
expands to become the dominant allele among individuals of European descent. This supports the hypothesis that this
locus may be under selection from mycobacteria or other pathogens that are recognized by TLR1 and its co-receptors.
These observations provide insight into the long standing host-pathogen relationship between human and mycobacteria
and highlight the key role of the TLR pathway in infectious diseases.
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Introduction
Leprosy is a chronic granulomatous disease affecting the skin
and peripheral nerves and caused by Mycobacterium leprae. Despite
its being the first identified pathogen in humans, leprosy remains
endemic in central Africa, Southeast Asia and South America with
more than 200,000 new cases per year globally. Our understand-
ing of the bacterial pathogenesis and interaction with the human
host is limited, because of the inability to culture the bacterium in
vitro. Nevertheless, twin studies [1], familial clustering [2] and
segregation analyses [3] studies have suggested that host genetics
play an important role in susceptibility to this infectious disease
with the heritability estimated up to 57% [4]. This allows genetic
research to help understand the immunity against M. leprae and
provide insight into the host-pathogen relationship.
Although several genetic loci have been reported to associate
with susceptibility to leprosy, candidates showing independent
replications are scanty, and the vast majority of the phenotypic
variation remains unexplained. To identify the genetic variants
affecting susceptibility to leprosy, we conducted a population
based case-control association study using a gene-centric 50 K
microarray covering variants in 2,092 genes throughout the
genome [5], and found TLR1 and HLA-DRB1/DQA1 as major
determinants of leprosy susceptibility. We also observe a high
degree of population differentiation at the TLR1 gene, suggesting
that mycobacterial diseases may have contributed to the evolution
PLoS Pathogens | www.plospathogens.org 1 July 2010 | Volume 6 | Issue 7 | e1000979of this locus. These observations refine our understanding of the
long interaction between human and mycobacteria and suggest
that modulation of the TLR1 pathway may be valuable in future
treatment of mycobacterial diseases.
Results
Primary association analysis
We genotyped 258 leprosy cases and 300 controls recruited from
New Delhi, India where the disease is prevalent. Diagnosis of
leprosy was made by at least two independent leprologists with
standard histopathological examination of affected skin lesions.
After quality control filtering, the genotype rate was 99.5% with
separate multi-dimensional scaling (MDS) and principal component
analysis (PCA) showing minimal population substructure in the 448
individuals (209 cases and 239 controls) carried forward for analysis
(FiguresS1andS2,Tables S1andS2). The strongest association
was observed at the human leukocyte antigen (HLA) class II locus at
chromosome 6p21 (Figure 1), with two SNPs showing genome-
wide level of association (rs9270650 P=6.4610
210 and rs1071630
P=8.5610
210, Table 1, Table S3).
Human leukocyte antigen (HLA) region
We genotyped variants with P,1610
24 in the primary
association analysis, using the Sequenom MassArray primer
extension assay in an independent case-control cohort recruited
from Kolkata (220 cases and 162 controls), West Bengal as part of
the replication study. To further minimise the possibility of
population stratification resulting in spurious association, we
undertook a family-based study recruited from Kumbakonam
(N=941 with 161 families), Tamil Nadu in south India which is
robust to population substructure [6]. These results provide further
support for the HLA associations, with rs1071630 located in HLA-
DQA1 showing convincing evidence of association across these
populations (case-control P=4.9610
214, OR=0.43, 95%
CI=0.35–0.54, Table 1, Figure 2, Figure S3 and Table S4).
Strong evidence of association was also observed with rs9270650 in
HLA-DRB1 (case-control P=3.1610
211, OR=2.24, 95%
CI=1.76–2.86, Table 1, Figure S3 and Table S4). Despite
the more significant associations observed in the recessive models as
compared to the dominant models, the allelic tests remained most
significant suggesting that the alleles may be acting with a
multiplicative effect (Table S5). The associations remained highly
significant after corrections for age and gender in logistic regression
models (Table S5). Statistical tests of heterogeneity showed similar
effect sizes between the multibacillary and paucibacillary subtypes
(Table S6). These results are consistent with a recently published
study conducted in the Han Chinese population, showing
association at the same locus with a similar effect size [7].
Conditional logistic regression analysis suggested that neither of
these two variants can alone account for the observed association
(Table S7), butinstead form bi-variatehaplotypes highlyassociated
with disease states (haplotype TC, case-control P=7.3610
215,
OR=0.41, 95% CI=0.33–0.52; haplotype CT, case-control
P=5.2610
212, OR=2.20, 95% CI=1.75–2.76, Table S8).
Individuals homozygous for the risk alleles at both loci are more
than eight times more susceptible to leprosy than their homozygous
protective counterparts (Figure S4 and Table S9).
Figure 1. Manhattan plot showing the primary association statistics for the 50 K microarray. Association statistics of the tuberculosis
cases versus controls are presented as negative logarithms of the P-values. The dotted grey line indicates the threshold P=1.0610
24.
doi:10.1371/journal.ppat.1000979.g001
Author Summary
Mycobacterium leprae is an obligate intracellular pathogen
that causes leprosy, a disease that shares a long history
with the human population but which remains endemic in
many parts of the world. Despite the fact that the genome
of M. leprae has been sequenced, our understanding of its
pathogenesis and interaction with the human host is
limited, in part due to the inability to culture the bacterium
in vitro. In this gene-centric microarray study, we have
genotyped SNPs in over 2,000 genes and identified TLR1
and HLA-DRB1/DQA1 as major leprosy susceptibility genes.
Studying the geographical distribution of this hypo-
functional TLR1 variant demonstrated extreme population
differentiation at this locus. These results suggest that
leprosy may have contributed to the evolution of this
genomic region, and provide insight into the long history
of the host-pathogen relationship between humans and
M. leprae.
Insight into Host-Pathogen Relationship
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Consistent direction of effect was also observed at the Toll-like
receptor (TLR) gene cluster at chromosome 4p14. The association
peaks at a non-synonymous variant rs5743618 (TLR1 I602S/
T1805G), which affects receptor translocation to the cell surface
[8], with a significant protective association against leprosy in both
New Delhi (P=1.3610
26, OR=0.27, 95% CI=0.1520.47) and
Kolkata (P=0.012, OR=0.40, 95% CI=0.20–0.83, Table 1,
Table S5). The combined statistic from these two case-control
populations showed strong evidence of association (P=5.7610
28,
OR=0.31, 95% CI=0.20–0.48). The Kumbakonam family study
showed a consistent direction of effect (P=0.090, OR=0.61, 95%
CI=0.35–1.09). Analyzed together with a small reported set of 57
cases and 90 controls in Turkey [8], the best estimate of risk for the
602S allele is OR=0.37 (95% CI=0.26–0.51) with an overall
P=1.7610
29 for the case-control studies (Table 1, Figure 2
and Table S5). This association is the strongest among all 75
SNPs genotyped in the 80 kb flanking region, and accounts for the
observed association in the locus (Table S10). The associations
remained significant after corrections for age and gender (Table
S5), with similar effect sizes between the multibacillary and
paucibacillary subtypes (Table S6). Haplotypic analysis identified
a haplotype containing the 602S variant that associated signifi-
cantly with leprosy susceptibility (CTTTCT, P=1.3610
26,
OR=0.29, 95% CI=0.18–0.48, Figures S5 and S6, Table
S11), although this magnitude of effect is similar to the single locus
association suggesting this effect is mainly driven by the 602S
association. In fact, this TLR1 variant shows the most consistent
association after HLA among the 2,092 genes tested in our
microarray. However, this association was not observed in the
recent GWA study [7], likely due to the absence of this SNP on the
array utilized by the Zhang et al, and the low power to detect the
association by proxy SNPs due to the low allele frequency (1.7%)
in the Han Chinese population.
Previous candidates in leprosy susceptibility
The gene-centric microarray allows genic SNPs to be interrogated
at a high density including putative leprosy susceptibility candidates
(Table 2). Notably, evidence of association was observed at SNPs
flanking MICA (rs12660741, P=9.9 610
25)a n dTNF (rs3093662,
P=3.2 610
24), both located on chromosome 6. These associations
remained nominally significant after correcting for the HLA variants
rs9270650 and rs1071630. These data suggest that these genes may
be involved in immunity against M. leprae. However, we did not
replicate the reported association with the LTA promoter variant [9]
(rs2239704/LTA +80, P=0.20), or with the regulatory variants in
PARK2/PACRG within the New Delhi case-control study as
previously described [10]. Despite consistent replication at the
Chromosome 13 locus (C13orf31 and CCDC122), we did not observe
anysignificantassociationwithvariantsinNOD2,TNFSF15 or RIPK2
[11] that were identified in the recent GWA study [7]. The
differences may be due to population specific effects which have been
described in other diseases [12] or differences in allele frequencies.
Population differentiation at TLR1
Infectious diseases have been a major selective force during
human evolution [13,14] and have contributed to the diversity of
the mammalian HLA genes [15]. Several studies have shown that
this TLR gene cluster is highly differentiated between populations
[16,17,18]. To further investigate the geographic distribution of this
locus, we genotyped 12 SNPs in this region in 1,463 individuals
from 6 populations (New Delhi, Kolkata and Kumbakonam from
India, Malawi, Gambia and United Kingdom, Table S1). We
observed a high degree of population differentiation at this locus
[16] (Figure S7), which peaks at the I602S variant with a FST value
higher than any other variants in this locus (Table S12). To
compare the degree of differentiation with the rest of the genome,
we genotyped I602S in the CEU, CHB and YRI populations [19]
and observed extreme differentiation (FST=0.55) among over 3
Table 1. Association statistics of rs1071630, rs9270650 and rs5743618 in the different cohorts.
HLA-DRB1/DQA1
SNP Cohort Cohort Type Allele Case Freq Control Freq T:U OR 95% CI P-value
rs1071630 New Delhi Case-control T 68.6% 47.8% - 2.38 1.80–3.15 8.5610
210
Kolkata Case-control T 71.8% 53.9% - 2.17 1.53–3.08 1.1610
25
Kumbakonam Family T - - 187:151 1.24 1.00–1.53 0.050
Combined case-control (Woolf’s test P=0.69) 2.30 1.85–2.86 4.9610
214
rs9270650 New Delhi Case-control C 42.9% 21.8% - 2.70 1.93–3.76 6.4610
210
Kolkata Case-control C 48.6% 34.1% - 1.83 1.28–2.59 7.5610
24
Kumbakonam Family C - - 156:120 1.30 1.03–1.65 0.030
Combined case-control (Woolf’s test P=0.11) 2.24 1.76–2.86 3.1610
211
TLR1
SNP Cohort Cohort type Allele Case Control T:U OR 95% CI P-value
rs5743618 New Delhi Case-control C 3.8% 13.0% - 0.27 0.15–0.47 1.3610
26
Kolkata Case-control C 3.6% 8.4% - 0.40 0.20–0.83 0.012
Turkey [8] Case-control C 26.3% 42.8% - 0.48 0.29–0.80 0.004
Kumbakonam Family C - - 19:31 0.61 0.35–1.09 0.090
Combined (Indian case-control, Woolf’s test P=0.37) 0.31 0.20–0.48 5.7610
28
Combined (all case-control, Woolf’s test P=0.33) 0.37 0.26–0.51 1.7610
29
The Pearson’s x
2 allelic test was presented for the association test in the case-control cohorts, and the transmission-disequilibrium-test was used for the association test
in the family-based cohort. The data from the Turkey cohort were retrieved from the study by Johnson et al.
doi:10.1371/journal.ppat.1000979.t001
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Mapping the global frequency of the I602S mutation in 15 different
populations reveals that the protective serine allele is derived and
rare in Africa, but expands in frequency to become the dominant
allele in Europe (Figure 3 and Figure S8). Today, more than
40% of individuals of European descent are homozygous for this
mutation. The ancestral isoleucine allele is crucial for protein
translocation to the cell membrane, which is abrogated by the
hydrophilic serine substitution resulting in a hypo-functional
phenotype [8,20,21] that associates with protection against an
important pathogen. Together with a recent study showing
signature of selection at this locus [22], these suggest that
mycobacteria may have contributed to the extreme population
differentiation at this locus. This provides insight into the host-
pathogen relationship between human and M. leprae.
Discussion
Despite the long history of leprosy and medical advances,
leprosy remains a scourge in many parts of the world. Our
understanding of the pathogenesis of M. leprae and its interaction
with humans is limited, in part due to the inability to culture the
bacterium in vitro. For this reason, there is greater reliance on
genetics to understand the disease and its causative pathogen.
Some progress has been made to identify genetic loci which
associate with susceptibility to leprosy; however the numbers of
candidates showing consistent replication across populations are
few. We here conduct a population based case-control association
study, surveying genetic variants in more than 2,000 genes
throughout the genome.
Our gene-centric study identified genetic variants at TLR1 and
HLA-DRB1/DQA1 as major determinants of leprosy susceptibility.
These associations showed a consistent direction of effect across
the populations under study, including the family samples from
Kumbakonam in South India although the two-sided association
statistic was borderline for the TLR1 variant (Table 1). These
results minimize the chance that the associations are spurious,
because the transmission disequilibrium test is known to be robust
to population stratification.
Figure 2. Association plots of the HLA class II and TLR 10/6/1 regions with leprosy susceptibility. The association statistics are presented as
negative logarithms of the P-values. The color scales correlates with the linkage disequilibrium r
2 with the most associated SNP in the respective region.
doi:10.1371/journal.ppat.1000979.g002
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immune response to M. leprae [21]. Our results advance our
understanding of human immunity to M. leprae. Firstly, this present
study is the first to show the consistent effect of TLR1 on leprosy
susceptibility, at a significance level exceeding a genome-wide
threshold. Secondly, the TLR1 association is the most significant
after the HLA class II locus, of the greater than 2,000 loci
surveyed. Although this result does not exclude the possibility of
other genes involved in leprosy, it does support that the innate
immune system, activated by the TLR receptors, plays a
significant role in the defence against M. leprae in humans.
Thirdly, the hydrophilic serine substation (TLR1 I602S) has been
shown to result in a functional knockout phenotype [8,23].
Although this mutation is rare in Africa and Asia, our data suggest
that a significant proportion of individuals of European descent
are homozygous for this knockout variant. These functional TLR1
knockout individuals have a normal immunological phenotype
and are protected against leprosy, suggesting that M. leprae may
have utilized TLR1 as part of its pathogenesis mechanisms, as
certain bacteria are known to produce homologues of the TLR1
signaling domain to subvert the innate immune responses [24].
Collectively, these results suggest that modulation of the TLR1
pathway may be valuable in future treatment of mycobacterial
diseases without significant side effects.
When we compare these results to the recently published GWA
study [7], we observed both consistent and discrepant results with
the different genetic loci. Reassuringly, both studies confirm the
class II HLA locus as a major leprosy susceptibility locus, a finding
consistent with early studies reporting association of HLA with
leprosy [25,26]. Consistent findings were also observed for genetic
variants at C13orf31 and CCDC122 [27]. However, separate
genotyping of the reported SNPs did not replicate the associations
at the NOD2, TNFSF15 or RIPK2 genes [27]; nor did the Zhang
et al. study report any notable association at the TLR1 locus [7].
The disparity at the TLR1 locus is likely due to the low allele
frequency of TLR1 I602S, and that the haplotype carrying this
variant would have low power to detect the association. For the
other associated genes (NOD2, TNFSF15 and RIPK2) there could
Figure 3. Population differentiation at TLR1 I602S. The pie charts show the global distribution of TLR1 I602S allele frequency. Side panel shows
the multiple amino acid sequence alignment around the polymorphism in different species.
doi:10.1371/journal.ppat.1000979.g003
Table 2. Association statistics of SNPs in genes previously reported to associate with susceptibility to leprosy.
Chr Gene No. of SNPs Best SNP OR 95% CI P-value Bonferroni P-value
1 IL10 13 rs1554286 1.52 1.15–1.99 0.003 0.039
2 SLC11A1 9 rs13062 1.39 1.03–1.88 0.032 0.288
4 TLR2 8 rs1339 0.72 0.47–1.09 0.116 0.928
5 IL12B 15 rs919766 2.82 1.22–6.52 0.011 0.165
6 MICA 13 rs12660741 2.15 1.45–3.18 9.9610
25 0.001
6 MICB 8 rs3828917 0.32 0.16–0.66 0.001 0.008
6 LTA 15 rs1121800 1.20 0.92–1.56 0.19 1.000
6 TNF 15 rs3093662 0.29 0.13–0.63 3.2610
24 0.005
6 PARK2 [10] 2 rs6455767 0.73 0.46–1.15 0.177 0.354
6 PACRG [10] 1 rs9458710 1.27 0.68–2.36 0.454 0.454
9 TLR4 28 rs7044464 1.57 1.05–2.35 0.029 0.812
12 VDR 62 rs2254210 0.60 0.41–0.88 0.008 0.496
16 NOD2 [27] 27 rs4785224 0.65 0.46–0.92 0.012 0.324
19 IL12RB1 9 rs436857 0.77 0.51–1.16 0.207 1.000
This table shows the number of SNPs and the best SNP in each gene, with the Bonferroni P-value corrected with the number of SNPs in the region. Results previously
presented are referenced as denoted.
doi:10.1371/journal.ppat.1000979.t002
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effect sizes of variants in these genes are moderate compared to the
HLA and chromosome 13 locus. Assuming these effect estimates
are real, the present study will have less power to detect these
associations. Another possibility is a population specific effect
whereby variants in these genes confer susceptibility in the Chinese
population but not in the Indians. Given the significant differences
in the genetic composition between the Indian and Chinese [28],
this may have contributed to the heterogeneous signals between
the studies. Previous studies have described population specific
genetic effects for other diseases [12]. Furthermore, despite the
relative homogenous population of M. leprae, the 16 mycobacterial
subtypes highly correlated with the geography can be readily
identified [29]. Given the highly specialized nature of the immune
system, these mycobacterial strains may activate the host immune
response in slightly different ways, accounting for overlapping yet
some discordant results between the studies. Finally, we cannot
exclude the possibility that NOD2, TNFSF15 and RIPK2 are not
true leprosy susceptibility loci.
This study provides insight into the host-pathogen relationship
between human and M. leprae. Our data showed that the TLR1
locus is more highly differentiated as compared with the rest of the
genome. Although the historical selective agents behind this
differentiation are difficult to ascertain, our data suggests that
mycobacterial infections may contribute to such a high degree of
differentiation. Several studies have suggested that leprosy may be
associated with reduced reproductive fitness [30,31], and the all-
cause mortality of lepromatous leprosy was reported to be at least
3.5 times of the general populations [32,33]. These factors,
together with the long human co-existence with M. leprae [34] and
intense social stigma associated with the disease [35], suggest that
leprosy may have contributed to the present global distribution of
human TLR1. Other infectious diseases especially tuberculosis
could have also contributed, given the overlapping antigenic
repertoire and immunogenicity of mycobacterial species, despite a
lack of association in a Gambian case-control population due to
low allele frequency (Table S13). However, given the lack of data
on concurrent selective events, this hypothesis remains difficult to
prove and other mechanisms are possible including genetic drift,
population migration or bottlenecks, or a combined effect of two
or more of these mechanisms.
In conclusion, this study suggests that TLR1 and HLA-DRB1/
DQA1 are important genetic determinants of susceptibility to
leprosy. This study also shows a protective effect against an
important pathogen with a hypo-functional TLR1 variant. These
observations further highlight the key role of the TLRs in
infectious diseases [36,37] and suggest that modulation of the
TLR1 pathway may be valuable in future treatment of
mycobacterial diseases.
Materials and Methods
Ethics statement
For the New Delhi cohort of samples, informed written consents
following the Indian Council of Medical Research (ICMR)
specification were obtained from all the individuals whose blood
samples were collected. The study was approved by the Jawaharlal
Nehru University ethics committee. For the Kolkata cohort of
samples, approval was obtained from the ICMR and consent was
obtained from the Tropical School of Calcutta and the Swasti
Blood Donor Centre at Kolkata. For the Kumbakonam samples,
ethical approval was obtained from the ICMR, New Delhi and
Hindu Mission Hospital in Kumbakonam.
Subjects
We genotyped 258 leprosy patients and 300 controls from New
Delhi [38]. After quality control filtering with call rates (.95% for
SNPs and .90% for samples), minor allele frequency (.1%),
Hardy-Weinberg equilibrium (P.1610
26), relatedness (,20%),
heterozygosity (22–27%) and outlying ancestry (within 97.5
th
percentile), the genotype rate was 99.5% with separate multi-
dimensional scaling (MDS) and principal component analysis
(PCA) showing minimal population substructure in the 448
individuals (209 cases and 239 controls) carried forward for
analysis. The replication studies included 220 leprosy patients and
162 controls from Kolkata, and 941 individuals from 246 families
from Kumbakonam [39], with which 299 individuals (168 cases
and 131 controls) from Kolkata and 852 individuals from
Kumbakonam were included after quality control filtering.
Diagnosis and classification of leprosy was based on clinical and
microscopic examination of the skin lesions. Patients were
classified either as multibacillary (MB, with bacterial index .0),
a group that included patients with lepromatous (LL), borderline
lepromatous (BL) and borderline (BB) leprosy, or as paucibacillary
(PB, with bacterial index of 0) which included patients with
borderline tuberculoid (BT) and tuberculoid (TT) leprosy.
Paucibacillary leprosy was characterized by the presence of large
well-defined skin lesions which were less than five in number, dry
and with almost 90–100% loss of sensation. Multibacillary leprosy
was characterized by the presence of six or more skin lesions that
were smaller in size, tending to be bilaterally symmetrical with
about 10–40% loss of sensation. The study was approved by the
relevant ethics committee. Informed consent was obtained from
individuals whose blood samples were collected. In addition, we
have also genotyped a total of 1,463 individuals from the
Kumbakonam, India, Gambia, Malawi, United Kingdom, Tomsk
and Tuva of Russia, and HapMap CEU, CHB and YRI
populations [19] for the population differentiation study.
Genotyping and quality control
All individuals in the New Delhi cohort were genotyped with the
Illumina IBC gene-centric 50 K array [5]. The data quality
control and analysis were performed using PLINK [40]. Multi-
dimensional scaling (MDS) and principal component analysis
(PCA) were carried out with PLINK and EIGENSTRAT to
remove population outliers. The microarray genotypes more than
48,000 SNPs distributed in approximately 2,100 genes throughout
the genome, including 3,470 non-synonymous markers. A total of
209 leprosy cases and 239 controls were carried forwarded for
analysis. The SNPs in the replication studies and the population
differentiation analysis were genotyped using the Sequenom
MassArray primer extension assay. The TLR1 I602S polymor-
phism was additionally genotyped with a restriction enzyme
digestion assay (PstI), and the rs1071630 with a primer induced
restriction assay (MlyI).
Analysis
Separate MDS and PCA analyses were performed in PLINK to
visualize the population structure in the New Delhi cohort
(Figure S1), and individuals with outlying ancestry were removed.
The analysis was performed in the resultant set of individuals. The
primary test of association in the New Delhi and Kolkata cohorts
was carried out with the Pearson’s x2 allelic test, Cochran-
Armitage trend test and logistic regression (Table S5); although
the allelic test statistics were used in the main text and tables unless
otherwise specified. The transmission-disequilibrium-test was used
for the Kumbakonam family cohort. Both analyses were
performed in PLINK. The primary association with the allelic
Insight into Host-Pathogen Relationship
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associations at TLR1 and HLA-DRB1/DQA1 were further tested
in a logistic regression model with correction for age, gender and
the first MDS component (Table S5). As this study involves
genotypes of genic instead of random SNPs, the quantile-quantile
(QQ) plot was generated with comparison to the statistics of the
same SNPs in the WTCCC Crohn’s disease, rheumatoid arthritis
and type 1 diabetes cohorts in addition to the expected values
under the null hypothesis (Figure S2), which suggests that the
statistics are not inflated by population substructure. The Mantel
Haenszel statistics was used to combine data from case-control
cohorts, but only when there was no significant heterogeneity in
odds ratio between studies indicated by the Woolf’s test. The
haplotypic analysis was performed by Haploview, with the
haplotypes reconstructed according to the confidence interval
definition [41]. The fixation index FST was used for the population
differentiation analysis. Let pi denote the allele frequency of the ith
population and p-bar denote the mean allele frequency, the FST
value is given by
FST~
P K
i~1
pi{p ðÞ
2
n ðÞp ðÞ1{p ðÞ
where n is the number of populations in comparison. The
haplotype diversity analysis was performed with Haplosuite [42].
Accession numbers
Genes. Toll-like receptor 1; TLR1 (NCBI GeneID:7096);
HLA-DRB1 major histocompatibility complex, class II, DR beta
1; HLA-DRB1 (NCBI GeneID:3123); HLA-DQA1 major
histocompatibility complex, class II, DQ alpha 1; HLA-DQA1
(NCBI GeneID:3117); interleukin 10; IL10 (NCBI GeneID:3586);
solute carrier family 11; SLC11A1 (NCBI GeneID:6556); Toll-like
receptor 2; TLR2 (NCBI GeneID:7097); interleukin 12b; IL12B
(NCBI GeneID:3593); MHC class I polypeptide-related sequence
A; MICA (NCBI GeneID:4276); MHC class I polypeptide-related
sequence B; MICB (NCBI GeneID:4277); lymphotoxin alpha; LTA
(NCBI GeneID:4049); tumor necrosis factor; TNF (NCBI
GeneID:7124); Parkinson disease 2, parkin; PARK2 (NCBI
GeneID:5071); PARK2 co-regulated; PACRG (NCBI
GeneID:135138); Toll-like receptor 4; TLR4 (NCBI GeneID:
7099); vitamin D receptor; VDR (NCBI GeneID:7421); interleukin
12 receptor, beta 1; IL12RB1 (NCBI GeneID:3594); nucleotide-
binding oligomerization domain containing 2; NOD2 (NCBI
GeneID:64127); receptor-interacting serine-threonine kinase 2;
RIPK2 (NCBI GeneID: 8767); tumor necrosis factor (ligand)
superfamily, member 15; TNFSF15 (NCBI GeneID:9966);
chromosome 13 open reading frame 31; C13orf31 (NCBI
GeneID: 144811); coiled-coil domain containing 122; CCDC122
(NCBI GeneID: 160857).
Supporting Information
Figure S1 Multi-dimensional scaling (MDS, left) and principal
component analysis (PCA, right) of New Delhi Indian and
HapMap samples. The first two components from the pairwise
matrix were plotted for the New Delhi individuals (black) in this
study, along with 210 unrelated samples from the International
HapMap Project (CEU - red, CHB+JPT - blue, YRI - green) [19].
Crosses in grey represented samples removed from the analysis
due to outlying ancestry.
Found at: doi:10.1371/journal.ppat.1000979.s001 (0.08 MB JPG)
Figure S2 Quantile-quantile (QQ) plot of overlapping SNPs
between the New Delhi leprosy and WTCCC studies. The dotted
line shows expected association statistics under the null hypothesis.
The coloured triangles represent the association statistics of the
intra-genic SNPs in the New Delhi leprosy and the WTCCC
Crohn’s disease, rheumatoid arthritis and type 1 diabetes cohorts
respectively. The observed statistics for the WTCCC Crohn’s
disease cohort using random SNPs are also shown in dark green.
Found at: doi:10.1371/journal.ppat.1000979.s002 (1.44 MB PDF)
Figure S3 Forest plots showing the association statistics in the
primary and replication studies. The statistics were calculated with
the Pearson’s x
2 allelic test with 1 degree of freedom.
Found at: doi:10.1371/journal.ppat.1000979.s003 (0.48 MB JPG)
Figure S4 The odds of leprosy infection against the double
homozygous protective group. The graph shows the odds of
infection among individuals carrying zero to four risk alleles for the
SNPs rs9270650 and rs1071630.
Found at: doi:10.1371/journal.ppat.1000979.s004 (0.00 MB PDF)
Figure S5 The pattern of linkage disequilibrium at the TLR 10/6/1
region, with the shades of red and black indicating the corresponding
D’ and r
2 values respectively. The SNP TLR1 I602S (rs5743618) is
labelled in green.
Found at: doi:10.1371/journal.ppat.1000979.s005 (0.86 MB JPG)
Figure S6 The pattern of linkage disequilibrium around the
SNP TLR1 I602S (rs5743618). The haplotype was reconstructed
using the confidence interval definition in Haploview [41].
Found at: doi:10.1371/journal.ppat.1000979.s006 (0.11 MB JPG)
Figure S7 Visualization of the haplotype diversity in the TLR
10/1/6 region. The figure represents the haplotype distribution
across the six populations, where each chromosome is either
mapped uniquely to one of twelve possible canonical haplotypes or
mapped as a mosaic of the twelve haplotypes. The canonical
haplotypes are defined as the haplotypic forms that most of the
2,392 chromosomes are similar to. Each color represents a unique
canonical haplotype and the same color scheme is used for the six
panels. The purple colour represents the canonical haplotype
containing the TLR1 I602S variant.
Found at: doi:10.1371/journal.ppat.1000979.s007 (0.30 MB JPG)
Figure S8 Pairwise FST of TLR1 I602S in 15 different
populations. Apart from the six population described, we
additionally genotype three HapMap populations (CEU, CHB
and YRI) [19] and two Russian populations (Tomsk and Tuva)
and retrieved data from more populations from literature [8,43].
The yellow-to-red scale indicates low-to-high FST value and bars
indicate frequency of the 602S allele.
Found at: doi:10.1371/journal.ppat.1000979.s008 (0.44 MB JPG)
Table S1 Study design. Outline of numbers of individuals in
each of the analyses performed in this study. Retrieved data from
published literature or public datasets are referenced as indicated
Found at: doi:10.1371/journal.ppat.1000979.s009 (0.05 MB
DOC)
Table S2 Quality control criteria for the 50 K microarray
genotyping for both samples and SNPs.
Found at: doi:10.1371/journal.ppat.1000979.s010 (0.03 MB
DOC)
Table S3 Association statistics of all SNPs with P,1610
24 in
the Pearson’s x
2 test in the primary association analysis in the New
Delhi cohort. Statistically significant associations in the New Delhi
cohort were verified with a logistic regression model, correcting for
sex and age as covariates.
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PLoS Pathogens | www.plospathogens.org 7 July 2010 | Volume 6 | Issue 7 | e1000979Found at: doi:10.1371/journal.ppat.1000979.s011 (0.09 MB
DOC)
Table S4 Association statistics of SNPs in the replication cohorts
with susceptibility to leprosy. All SNPs with nominal P,0.05 with
the same direction in either of the replication cohorts were
highlighted in bold.
Found at: doi:10.1371/journal.ppat.1000979.s012 (0.10 MB
DOC)
Table S5 Full genotypic counts and association statistics for
SNPs rs1071630, rs9270650 and rs5743618 (I602S) under
different genetic models. All the models in Pearson’s x
2 represent
1-df test except the genotypic model which has 2 degrees of
freedom.
Found at: doi:10.1371/journal.ppat.1000979.s013 (0.06 MB
DOC)
Table S6 Stratified association analyses (leprosy type and age)
and linear regression analysis (age of onset) for the three replicated
SNPs rs1071630, rs9270650 and rs5743618 (I602S) at HLA-
DRB1/DQA1 and TLR1. The Pearson’s x
2 test was used for the
stratified analyses, and the test of heterogeneity was performed
with Woolf’s test.
Found at: doi:10.1371/journal.ppat.1000979.s014 (0.05 MB
DOC)
Table S7 Conditional logistic regression analysis of SNPs
associated with leprosy susceptibility (P,0.05) at the HLA-
DRB1/DQA1 locus.
Found at: doi:10.1371/journal.ppat.1000979.s015 (0.04 MB
DOC)
Table S8 Bi-variate haplotypic analysis with SNPs rs9270650-
rs1071630 in the HLA. The P-value statistics in each population
were given by the likelihood ratio test in PLINK [40]. The
combined values were given by the Mantel Haenszel statistics after
confirming non-heterogeneity with Woolf’s test of heterogeneity.
Found at: doi:10.1371/journal.ppat.1000979.s016 (0.07 MB
DOC)
Table S9 Allelic dosage analysis for number of risk alleles at
SNPs rs9270650 and rs1071630 on susceptibility to leprosy.
Found at: doi:10.1371/journal.ppat.1000979.s017 (0.03 MB
DOC)
Table S10 Conditional logistic regression analysis of SNPs
associated with leprosy susceptibility (P,0.05) on the TLR1 I602S
polymorphism.
Found at: doi:10.1371/journal.ppat.1000979.s018 (0.03 MB
DOC)
Table S11 Haplotypic analysis of the TLR 10/1/6 locus using
SNPs rs7660429, rs11725309, rs10004195, rs7663239, rs5743618
(I602S) and rs4833095 in the New Delhi leprosy cohort.
Found at: doi:10.1371/journal.ppat.1000979.s019 (0.03 MB
DOC)
Table S12 Pairwise and global FST statistics of the 12 SNPs
genotyped in the six populations recruited from New Delhi,
Kolkata, Kumbakonam of India, Malawi, The Gambia and the
United Kingdom. The SNP rs5743618 (TLR1 I602S) is highlight-
ed in bold.
Found at: doi:10.1371/journal.ppat.1000979.s020 (0.05 MB
DOC)
Table S13 Association statistics of rs5743618 (TLR1 I602S) in a
Gambian tuberculosis case control population.
Found at: doi:10.1371/journal.ppat.1000979.s021 (0.03 MB
DOC)
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